SABBY MANAGEMENT, LLC - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 58 filers reported holding PLURISTEM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$242,000
-61.5%
50,822
-14.9%
0.05%
-50.0%
Q3 2020$629,000
+139.2%
59,730
+101.1%
0.09%
+77.4%
Q2 2020$263,000
-62.7%
29,699
-84.5%
0.05%
-81.9%
Q1 2020$705,000
+217.6%
192,049
+240.3%
0.29%
+372.6%
Q4 2019$222,000
+59.7%
56,442
+51.8%
0.06%
-17.3%
Q3 2019$139,00037,1910.08%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Values First Advisors, Inc. 49,111$517,0000.48%
Aristides Capital LLC 31,300$330,0000.23%
ARK Investment Management 1,743,618$18,360,0000.11%
SABBY MANAGEMENT, LLC 59,730$629,0000.09%
MEITAV INVESTMENT HOUSE LTD 152,438$1,605,0000.08%
Shepherd Financial Partners LLC 22,070$232,0000.06%
Savior LLC 3,393$36,0000.04%
ETF MANAGERS GROUP, LLC 57,586$554,0000.02%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 52,300$551,0000.02%
Focused Wealth Management, Inc 6,000$63,0000.01%
View complete list of PLURISTEM THERAPEUTICS INC shareholders